We use privacy-friendly analytics. Read our privacy policy.

Compound Profile

Boswellia AKBA Standardized

Joint function; inflammatory discomfort; safety screen: pregnancy caution; anticoagulants; GI irritation.

Use extra caution — Review medications, pregnancy status, chronic conditions, and clinician guidance before use. Details

Last reviewed: Report a correctionProfile-wide ·D Preliminary
Boswellia AKBA Standardized monograph visual
Generated profile category visual

At a glance

From this profile's structured data
Evidence
Grade D
Safety
Safety evidence: limited short-term human evidence for specific Boswellia extracts.
Profile context
5-lipoxygenase, leukotriene pathways
Next steps

Continue reading

Quick stats

Evidence level
Preliminary evidence
Typical onset
Varies by prep
Safety rating
Use extra caution: Interaction risk
Best for
5 Lipoxygenase, Leukotriene Pathways

Safety

Safety & Cautions

High caution

Caution level: High. Multiple caution categories apply, or the record uses avoid/contraindication language.

  • Interaction-AwareMedication or interaction context is explicitly noted.
  • Liver-SensitiveLiver-related caution language appears in the profile.
  • Anticoagulant CautionBleeding or anticoagulant-adjacent caution language is present.
  • Pregnancy/Breastfeeding CautionPregnancy or breastfeeding caution language is present.
Safety evidence
limited short-term human evidence for specific Boswellia extracts
Who should avoid this?
No specific evidence-backed contraindication is documented for this profile. This is not the same as established safety.
Talk to a professional if
you use relevant medications, you are pregnant or breastfeeding, surgery is planned or recent, you have a condition named in this safety summary.

Osteoarthritis trials did not show a clear excess of adverse events, but formulations and reporting varied; pregnancy, breastfeeding, surgery, bleeding, liver, kidney, long-term use, and medication-specific interaction safety remain insufficient.

Evidence Summary

Profile-wide ·D Preliminary

Evidence lens

Early signal that needs stronger human replication before practical claims.

PreliminaryPreliminary evidence

Human clinical evidence: Not the primary signal

Mechanistic / preclinical: Mechanism mapped — Inflammatory Mediator Suppression · Leukotriene Pathway Modulation · Antioxidant Support

Research maturity: Theoretical / mechanistic research — Mechanistic or unresolved evidence is kept separate from established human outcomes.

Safety boundary: Safety note available — Review medications, pregnancy status, chronic conditions, and clinician guidance before use.

Evidence Strength

Confidence estimate based on the design quality and consistency of published clinical trials.

Preliminary evidence

Boswellia AKBA Standardized has a preliminary evidence rating.

Inflammation SupportLongevity
Effects
2
How evidence grades work

Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.

Strong
Multiple RCTs, consistent direction, adequate effect size
Moderate
Some RCTs or consistent observational data in humans
Preliminary / Mixed
Animal or in-vitro only, or conflicting human data
Traditional / Theoretical
Traditional use only; no controlled human trials

How Boswellia AKBA Standardized Works

Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.

Mechanism Pathway — How Boswellia AKBA Standardized Works

How Boswellia AKBA Standardized WorksBoswellia AKBA Standardized acts on biological target pathways via anti inflammatory, leading to 5 lipoxygenase.Boswellia AKBA StandardizedBiological TargetBiological pathwayAnti Inflammatory5 LipoxygenaseObservable outcome
CompoundTarget / ReceptorMechanismEffect / Outcome

Dosing

Common form
capsule or standardized extract
No standardized dose
Our source data records the usual product form for this ingredient but no studied dose. Preparations differ widely, so follow the standardization on the product you actually have and speak to a clinician before starting.
Mechanisms & biological pathways

Preclinical mechanism details from scientific profiles; these represent plausible pathways but do not guarantee clinical efficacy in humans.

  • Inflammatory Mediator Suppression
  • Leukotriene Pathway Modulation
  • Antioxidant Support
  • Inflammatory Signaling Modulation
  • 5 Lipoxygenase Inhibition

Guides that use Boswellia AKBA Standardized

Continue exploring

Related research paths

Compare & Sourcing

Compare side-by-side tradeoffs or verify active marker guidelines.

Free safety checklist

Get the Boswellia AKBA Standardized evidence notes

Occasional research updates, safety context, and product-quality checks for supplement decisions.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.

Safety first · Harm reduction

This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.

Learn how we evaluate confidence, safety, and intensity on the methodology page.

Editorial Review

Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.

Editorial Standards →

Help improve this profile

Was this useful for your research?

These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.

Was this evidence summary clear?

Did you find what you were researching?